Evaluation of a Pretest Scoring System (4Ts) for the Diagnosis of Heparin-Induced Thrombocytopenia in a University Hospital Setting

References

• . Linkins LA, Dans AL, Moores LK, ; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141( 2 suppl):e495S–e530S
   PubMed Web of Science ®Google Scholar
• . Warkentin TE. Heparin-induced thrombocytopenia: a clinicopathologic syndrome. Thromb Haemost. 1999;82(2):439–447
   PubMedGoogle Scholar
• . Stanton PE Jr, Evans JR, Lefemine AA, . White clot syndrome. South Med J. 1988;81(5):616–620
   Google Scholar
• . Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T's score. J Thromb Haemost. 2010;8(7):1483–1485
   Google Scholar
• . Warkentin TE. Heparin-induced skin lesions. Br J Haematol. 1996;92(2):494–497
   PubMed Web of Science ®Google Scholar
• . Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest. 2005;127(5):1857–1861
   PubMed Web of Science ®Google Scholar
• . Chong BH, Castaldi PA. Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia. Aust N Z J Med. 1986;16(5):715–716
   Google Scholar
• . Van der Linden T, Souweine B, Dupic L, Soufir L, Meyer P. Management of thrombocytopenia in the ICU (pregnancy excluded). Ann Intensive Care. 2012;2(1):42
   Google Scholar
• . Ohman EM, Granger CB, Rice L, ; Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005;19(1):11–19
   Google Scholar
• . Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355(8):809–817
   PubMed Web of Science ®Google Scholar
• . Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106(8):2710–2715
   PubMed Web of Science ®Google Scholar
• . Smythe MA, Koerber JM, Mattson JC. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest. 2007;131(6):1644–1649
   PubMed Web of Science ®Google Scholar
• . Oliveira GB, Crespo EM, Becker RC, ; Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008;168(1):94–102
   PubMedGoogle Scholar
• . Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108(9):2937–2941
   PubMed Web of Science ®Google Scholar
• . Warkentin TE, Eikelboom JW. Who is (still) getting HIT? Chest. 2007;131(6):1620–1622
   Google Scholar
• . Junqueira DR, Perini E, Penholati RR, Carvalho MG. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev. 2012;9:CD007557
   PubMedGoogle Scholar
• . Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96(5):1703–1708
   PubMed Web of Science ®Google Scholar
• . Nader ND, Khadra WZ, Reich NT, Bacon DR, Salerno TA, Panos AL. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg. 1999;68(5):1640–1643
   PubMed Web of Science ®Google Scholar
• . Selleng S, Malowsky B, Strobel U, . Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2010;8(1):30–36
   PubMed Web of Science ®Google Scholar
• . Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79(1):1–7
   PubMed Web of Science ®Google Scholar
• . Warkentin TE, Greinacher A, Gruel Y, Aster RH, Chong BH; Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–2500
   PubMed Web of Science ®Google Scholar
• . Lo GK, Sigouin CS, Warkentin TE. What is the potential for over-diagnosis of heparin-induced thrombocytopenia? Am J Hematol. 2007;82(12):1037–1043
   Google Scholar
• . Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6(8):1304–1312
   PubMed Web of Science ®Google Scholar
• . Lo GK, Juhl D, Warkentin TE, Siqouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–765
   PubMed Web of Science ®Google Scholar
• . Lillo—Le Louët A, Boutouyrie P, Alhenc—Gelas M, . Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost. 2004;2(11):1882–1888
   PubMed Web of Science ®Google Scholar
• . Cuker A, Arepally G, Crowther MA, . The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010;8(12):2642–2650
   PubMed Web of Science ®Google Scholar
• . Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis [published online ahead of print September 18, 2012]. Blood.
   Google Scholar
• . Horsewood P, Warkentin TE, Hayward CPM, Kelton JG. The epitope specificity of heparin-induced thrombocytopenia. Br J Haematol. 1996;95(1):161–167
   PubMed Web of Science ®Google Scholar
• . Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67(1):27–30
   PubMed Web of Science ®Google Scholar
• . Trehel—Tursis V, Louvain—Quintard V, Zarrouki Y, Imbert A, Doubine S, Stéphan F. Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU [published online ahead of print March 8, 2012]. Chest.
   Google Scholar
• . US Food and Drug Administration. Drugs to be discontinued, http://www.fda.gov/drugs/drugsafety/drugshortages/ucm050794.htm. Updated October 11, 2012. Accessed October 17, 2012
   Google Scholar
• . Warkentin TE. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program. 2011:143–149
   Google Scholar
• . Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Am J Ther. 2011;18(1):14–22
   PubMed Web of Science ®Google Scholar
• . Multz AS, Lisker GN. The management of suspected heparin-induced thrombocytopenia in US hospitals [published online ahead of print August 14, 2012]. Clin Appl Thromb Hemost.
   Google Scholar
• . Smythe MA, Koerber JM, Mehta TP, . Assessing the impact of a heparin-induced thrombocytopenia protocol on patient management, outcomes and cost. Thromb Haemost. 2012;108(5):992–998
   Google Scholar